Introduction: Takayasu arteritis (TA) is a rare, large vessel vasculitis, which is characterized by substantial morbidity and premature mortality. Several approaches have been used in the recent years for the management of the disease, with some promising results. The best therapeutic strategies still need to be identified. Areas covered: This article discusses the main clinical features of TA and the recent insights into diagnosis and treatments. A search has been undertaken on PubMed and Scopus databases and the most relevant references have been considered. Expert opinion: The identification of the most effective regimens able to control TA unrelenting vascular inflammation without undue toxicity remains a challenge. To define the validated biomarkers and the activity criteria reflecting the specific features of vascular inflammation, and possibly predicting its outcome, represents a critical challenge for physicians in the next years.
Management options for Takayasu arteritis / E. Tombetti, A. Manfredi, M.G. Sabbadini, E. Baldissera. - In: EXPERT OPINION ON ORPHAN DRUGS. - ISSN 2167-8707. - 1:9(2013), pp. 685-693.
|Titolo:||Management options for Takayasu arteritis|
TOMBETTI, ENRICO (Primo) (Corresponding)
|Parole Chiave:||angioplasty; medical therapy; surgery; Takayasu arteritis; TNF inhibitors|
|Settore Scientifico Disciplinare:||Settore MED/16 - Reumatologia|
Settore MED/09 - Medicina Interna
Settore MED/11 - Malattie dell'Apparato Cardiovascolare
|Data di pubblicazione:||2013|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1517/21678707.2013.827570|
|Appare nelle tipologie:||01 - Articolo su periodico|